Tag: next generation mRNA-based vaccines
GSK, CureVac team up to develop and manufacture vaccine against COVID-19 mutants
UK-based GlaxoSmithKline announced today that it has partnered with German pharmaceutical company CureVac to jointly develop next-generation mRNA vaccines for emerging COVID-19 variants.
The €150m...
Featured Article
Navigating energy price volatility with predictive intelligence
Energy price volatility has become a structural feature of modern electricity markets rather than a temporary disruption. For energy-intensive manufacturers and large commercial operators, fluctuating wholesale prices are reshaping how energy costs are managed, making reactive approaches increasingly inadequate.
